Related Experiment Video
Updated: Apr 19, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Serotypes and antibiotic resistance patterns in beta-hemolytic Streptococcus agalactiae isolates in colonized
María Del Carmen Liébana-Martos1, Jorge Cabrera-Alavargonzalez1, Javier Rodríguez-Granger1
1Servicio de Microbiología, Hospital Universitario Virgen de las Nieves, Granada, España.
Insights
Streptococcus agalactiae (GBS) serotype distribution and antibiotic resistance are crucial for developing effective vaccines. Serotype V showed the most antimicrobial resistance in this study.
Area of Science:
- Microbiology
- Vaccinology
- Epidemiology
Background:
- Neonatal disease caused by Streptococcus agalactiae (GBS) is currently managed via prenatal screening and antibiotic prophylaxis.
- Understanding GBS serotype distribution is essential for developing alternative preventive strategies like polysaccharide vaccines.
Purpose of the Study:
- To determine the distribution of capsular serotypes among GBS strains from pregnant women and neonates.
- To assess the antimicrobial resistance patterns of these GBS strains.
Main Methods:
- 188 GBS strains from pregnant women and 24 from neonates were analyzed.
- Susceptibility testing for penicillin, erythromycin, and clindamycin was performed.
- Capsular serotyping utilized latex agglutination and PCR methods.
Main Results:
- High agreement (80.8%–95.8%) was observed between latex agglutination and PCR for serotyping.
- Antimicrobial resistance rates were higher in strains from pregnant women (erythromycin 16.5%, clindamycin 10.1%) compared to neonatal strains (erythromycin 8.3%, clindamycin 4.1%).
- Serotype iii was most frequent, while serotype v was most associated with antimicrobial resistance.
Conclusions:
- Epidemiological surveillance of GBS serotypes and antibiotic sensitivity is vital.
- Sensitive and specific methods are needed for ongoing monitoring of invasive GBS disease.
- This data supports the need for GBS vaccine development considering serotype prevalence and resistance.
Introduction:
Current preventive measures against neonatal disease caused by Streptococcus agalactiae (GBS) are prenatal screening and intrapartum antibiotic prophylaxis with appropriate antimicrobials. An alternative to this strategy would be the administration of a polysaccharide vaccine as the distribution of capsular serotypes of circulating strains needs to be known.
Methods:
A study was made of 188 strains from pregnant women carrying GBS and 24 newborns with neonatal disease. Susceptibility testing was performed with penicillin, erythromycin and clindamycin following CLSI standards, and capsular serotype was determined by two methods: latex agglutination and PCR.
Results:
Of the 188 strains of S.agalactiae from the pregnant women, there was 80.8% agreement in the results between the two techniques. Resistant to erythromycin and clindamycin was found in 16.5% and 10.1%, respectively. For neonatal strains, 95.8% of the results obtained by the two techniques were identical. The rates of resistance to erythromycin and clindamycin were 8.3% and 4.1%, respectively. In both groups, most frequently isolated serotype was iii, and the most related to antimicrobial resistance serotype was v.
Conclusion:
Epidemiological studies are necessary to continue surveillance of serotypes causing invasive disease and its antibiotic sensitivity patterns using sensitive and specific methods.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Bacterial Meningitis II: Pathophysiology
Staphylococcal Skin Infections
Development of the Oral Microbiota

